ES2123482T1 - Receptor de estrogeno. - Google Patents

Receptor de estrogeno.

Info

Publication number
ES2123482T1
ES2123482T1 ES97200903T ES97200903T ES2123482T1 ES 2123482 T1 ES2123482 T1 ES 2123482T1 ES 97200903 T ES97200903 T ES 97200903T ES 97200903 T ES97200903 T ES 97200903T ES 2123482 T1 ES2123482 T1 ES 2123482T1
Authority
ES
Spain
Prior art keywords
estrogen receptor
receptors
dna
new
estrogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES97200903T
Other languages
English (en)
Other versions
ES2123482T3 (es
Inventor
Sietse Mosselman
Rein Dijkema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26142641&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2123482(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of ES2123482T1 publication Critical patent/ES2123482T1/es
Application granted granted Critical
Publication of ES2123482T3 publication Critical patent/ES2123482T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN ADN AISLADO QUE CODIFICA NUEVOS RECEPTORES DE ESTROGENOS, LAS PROTEINAS CODIFICADAS POR DICHO ADN, RECEPTORES QUIMERICOS QUE INCLUYEN PARTES DE LOS NUEVOS RECEPTORES Y SUS USOS.
ES97200903T 1996-03-26 1997-03-25 Receptor de estrogeno. Expired - Lifetime ES2123482T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200820 1996-03-26
EP96203284 1996-11-11

Publications (2)

Publication Number Publication Date
ES2123482T1 true ES2123482T1 (es) 1999-01-16
ES2123482T3 ES2123482T3 (es) 2002-11-01

Family

ID=26142641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97200903T Expired - Lifetime ES2123482T3 (es) 1996-03-26 1997-03-25 Receptor de estrogeno.

Country Status (13)

Country Link
US (3) US7060490B1 (es)
EP (2) EP0798378B1 (es)
JP (1) JPH104986A (es)
KR (1) KR19980041692A (es)
AT (1) ATE212055T1 (es)
AU (1) AU715812B2 (es)
CA (1) CA2200423C (es)
DE (2) DE798378T1 (es)
DK (1) DK0798378T3 (es)
ES (1) ES2123482T3 (es)
GR (1) GR980300076T1 (es)
HK (1) HK1001978A1 (es)
HU (1) HU221411B1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009348A2 (en) 1995-09-08 1997-03-13 Karo Bio Ab Orphan receptor
US7157568B1 (en) 1997-08-05 2007-01-02 American Home Products Corporation Human estrogen receptor-β
US6222015B1 (en) 1997-09-08 2001-04-24 Merck & Co., Inc. Estrogen receptor
JP4307708B2 (ja) * 1997-09-08 2009-08-05 メルク エンド カムパニー インコーポレーテッド エストロゲン受容体
DE19839115A1 (de) * 1998-08-27 2000-03-09 Ihf Inst Fuer Hormon Und Fortp Klonierung und Expression von Rinder Estrogenrezeptor-beta
EP1131336B1 (en) 1998-11-20 2002-08-28 Akzo Nobel N.V. Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
DE19855013C2 (de) * 1998-11-20 2001-09-13 Schering Ag Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
AU2001256164A1 (en) 2000-03-01 2001-09-12 Akzo Nobel N.V. Chroman derivatives as estrogenic compounds
US20040033600A1 (en) 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
CA2404253C (en) 2000-03-22 2014-05-13 Rohm And Haas Company Novel ecdysone receptor-based inducible gene expression system
TWI225068B (en) 2000-06-06 2004-12-11 Akzo Nobel Nv Anellated steroid compounds having contraceptive and anti-osteoporosis activity
US8105825B2 (en) 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
CA2438133C (en) 2001-02-20 2015-01-27 Rheogene, Inc. Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
US9493540B2 (en) 2001-02-20 2016-11-15 Intrexon Corporation Ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
DK1572862T3 (da) * 2001-02-20 2012-11-26 Intrexon Corp Kimære, retinoide x-receptorer og deres anvendelse i et hidtil ukendt ecdysonrecepttorbaseret inducerbart genekspressionssystem
JP4328094B2 (ja) 2001-02-20 2009-09-09 イントレクソン・コーポレイション 新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
WO2003012113A2 (en) * 2001-08-02 2003-02-13 Gencell S.A. Inducible expression systems employing ppar transcriptional activators
EP1288303A1 (en) * 2001-08-23 2003-03-05 Aventis Pharma S.A. Inducible expression systems employing PPAR transcriptional activators
EP1436394A4 (en) 2001-09-26 2004-12-29 Rheo Gene Holdings Inc CICADA ECDYSON RECEPTOR NUCLEIC ACIDS, POLYPEPTIDES AND THEIR USE
AU2002327787A1 (en) * 2001-09-28 2003-04-07 Gordon L. Hager Glucocorticoid receptor nuclear translocation domain
TW200304371A (en) 2002-02-22 2003-10-01 Akzo Nobel Nv Substituted 10-ary1-11H-benzo [b] fluorenes and 7-ary1-5, 6-dihydro-benz [a] anthracenes for selective effects on estrogen receptors
US7674783B2 (en) 2002-11-22 2010-03-09 Dimera Inc. Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
US7304161B2 (en) 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7456315B2 (en) 2003-02-28 2008-11-25 Intrexon Corporation Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7935510B2 (en) 2004-04-30 2011-05-03 Intrexon Corporation Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
MX361717B (es) 2013-03-15 2018-12-14 Intrexon Corp Diacilhidrazinas que contienen boro.
AU2015317862A1 (en) 2014-09-17 2017-04-06 Intrexon Corporation Boron-containing diacylhydrazine compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0258401A4 (en) * 1986-02-20 1989-06-13 California Biotechnology Inc EUKARYOTIC EXPRESSION OF STEROID RECEPTOR PROTEINS.
US5217867A (en) * 1988-11-30 1993-06-08 The Salk Institute For Biological Studies Receptors: their identification, characterization, preparation and use
FR2649994A1 (fr) * 1989-06-30 1991-01-25 Aderegem Procede d'obtention d'un recepteur humain natif sauvage des oestrogenes et ses applications
AU8951191A (en) * 1990-10-29 1992-05-26 Dekalb Plant Genetics Isolation of biological materials using magnetic particles
CA2115452A1 (en) * 1991-09-17 1993-04-01 Ronald M. Evans Receptor of the thyroid/steroid hormone receptor superfamily
WO1997009348A2 (en) * 1995-09-08 1997-03-13 Karo Bio Ab Orphan receptor
US7157568B1 (en) * 1997-08-05 2007-01-02 American Home Products Corporation Human estrogen receptor-β

Also Published As

Publication number Publication date
US6713270B1 (en) 2004-03-30
EP1162264A2 (en) 2001-12-12
EP0798378B1 (en) 2002-01-16
HUP9700636A3 (en) 1999-01-28
GR980300076T1 (en) 1998-11-30
AU715812B2 (en) 2000-02-10
ATE212055T1 (de) 2002-02-15
HU221411B1 (en) 2002-09-28
CA2200423A1 (en) 1997-09-26
DE69709561D1 (de) 2002-02-21
CA2200423C (en) 2006-12-19
JPH104986A (ja) 1998-01-13
EP0798378A2 (en) 1997-10-01
KR19980041692A (ko) 1998-08-17
HUP9700636A2 (hu) 1998-04-28
US7060490B1 (en) 2006-06-13
DE69709561T2 (de) 2002-08-29
EP0798378A3 (en) 1997-12-29
AU1652197A (en) 1997-10-02
DK0798378T3 (da) 2002-04-29
HK1001978A1 (en) 1998-07-24
DE798378T1 (de) 1999-03-04
US6680368B1 (en) 2004-01-20
EP1162264A3 (en) 2002-05-15
HU9700636D0 (en) 1997-05-28
ES2123482T3 (es) 2002-11-01

Similar Documents

Publication Publication Date Title
ES2123482T1 (es) Receptor de estrogeno.
ES2168424T3 (es) Procedimiento para la sintesis selectiva de disulfuros de sililalquilo.
ES2164069T3 (es) Marcador electroquimioluminiscente mejorado para ensayos de sondas de adn.
HN1998000118A (es) 2 - aminopiridinas que contienen sustituyentes de anillos condensados.
NO994998D0 (no) Fusjonsproteiner
AR030760A1 (es) Nuevos acidos y polipeptidos nucleicos receptores
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
ES2191007T3 (es) Receptor tipo iii de tgf-beta, cdna que lo codifica y sus usos.
ES2106033T3 (es) Dominio extracelular de her2.
ES2193328T3 (es) Procedimiento para despolimerizar poliesteres.
HN1997000166A (es) 1-arilpirazoles plaguicidas
ES2184888T3 (es) Empleo de catalizadores de estaño, asi como mezclas reticulables que contienen estos catalizadores.
ES2127247T3 (es) Composiciones de fragancia y otras composiciones que contienen feromonas humanas.
ES2186018T3 (es) Procedimiento para preparar tolterodina.
ES2179274T3 (es) Tinta de seguridad.
AR008861A1 (es) COMPUESTOS DE LACTAMA E IMIDA HETEROCICLICOS DE ARALQUILO Y ARALQUILEDENO, COMPUESTOS INTERMEDIARIOS PARA SU SíNTESIS, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN.
ES2153106T3 (es) Aminofeniluracilos substituidos como herbicidas e insecticidas.
CY1107494T1 (el) Υποκατεστημενα παραγωγα πυριδυλμεθυλπιπepαζινης και πιπepιδινης, η παρασκευη τους και η χρηση τους για θepαπεια νοσων του κεντρικου νευρικου συστηματος (κνς)
ES2114876T3 (es) Hidroxialquilacion de fenoles o tiofenoles con carbonatos organicos ciclicos utilizando catalizadores de triorganofosfino.
HN1998003689A (es) Azetidinas
ES2161078T3 (es) Reactor de lecho fluidizado y su utilizacion.
HN1997000127A (es) Procedimiento e intermedios para preparar derivados de cromanol sustituidos.
MX9803634A (es) Difenileteroxazolinas y su empleo como agentes pesticidas.
MX9304580A (es) Proteina de tirosina-fosfatasa del tipo receptor de mamifero, molecula de adn que la codifica y proceso para su preparacion.
ES2168253T3 (es) Peptidos especificos para hcmv y su utilizacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 798378

Country of ref document: ES